Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mark FitzGerald

Showing results (231-240 of 325) with videos related to

Pageof 33
Sort By:
Trials|December 16, 2014
Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trialMary A De Vera, Mohsen Sadatsafavi, Nicole W Tsao, et al.
COPD|March 27, 2014
Quality assurance of spirometry in a population-based study -predictors of good outcome in spirometry testingWan C Tan, Jean Bourbeau, Denis O'Donnell, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 9, 2021
Reply to "As-needed budesonide-formoterol for adolescents with mild asthma: importance of lung function"Helen K Reddel, Paul M O'Byrne, J Mark FitzGerald, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 28, 2018
Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPDKate M Johnson, Abdollah Safari, Wan C Tan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 25, 2021
Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild AsthmaHelen K Reddel, Paul M O'Byrne, J Mark FitzGerald, et al.
Canadian Respiratory Journal|February 27, 2010
Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adultsM D Lougheed, C Lemière, S D Dell, et al.
Thorax|July 6, 2014
Exacerbations in non-COPD patients: truth or myth--authors' responseWan C Tan, Jean Bourbeau, Shawn Aaron, et al.
Respiratory Medicine|August 11, 2022
The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY studySarowar Muhammad Golam, Christer Janson, Richard Beasley, et al.
The Lancet. Respiratory Medicine|October 4, 2020
Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 studyPaul M O'Byrne, J Mark FitzGerald, Eric D Bateman, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 21, 2019
Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthmaArnaud Bourdin, Dominick Shaw, Andrew Menzies-Gow, et al.
Pageof 33

Showing results (231-240 of 325) with videos related to

Sort By:
Pageof 33
Trials|December 16, 2014
Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trialMary A De Vera, Mohsen Sadatsafavi, Nicole W Tsao, et al.
COPD|March 27, 2014
Quality assurance of spirometry in a population-based study -predictors of good outcome in spirometry testingWan C Tan, Jean Bourbeau, Denis O'Donnell, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 9, 2021
Reply to "As-needed budesonide-formoterol for adolescents with mild asthma: importance of lung function"Helen K Reddel, Paul M O'Byrne, J Mark FitzGerald, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 28, 2018
Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPDKate M Johnson, Abdollah Safari, Wan C Tan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 25, 2021
Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild AsthmaHelen K Reddel, Paul M O'Byrne, J Mark FitzGerald, et al.
Canadian Respiratory Journal|February 27, 2010
Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adultsM D Lougheed, C Lemière, S D Dell, et al.
Thorax|July 6, 2014
Exacerbations in non-COPD patients: truth or myth--authors' responseWan C Tan, Jean Bourbeau, Shawn Aaron, et al.
Respiratory Medicine|August 11, 2022
The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY studySarowar Muhammad Golam, Christer Janson, Richard Beasley, et al.
The Lancet. Respiratory Medicine|October 4, 2020
Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 studyPaul M O'Byrne, J Mark FitzGerald, Eric D Bateman, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 21, 2019
Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthmaArnaud Bourdin, Dominick Shaw, Andrew Menzies-Gow, et al.
Pageof 33